This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Elliott MJ et al. (1994) Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet 344: 1125–1127
Maini RN et al. (1998) Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 41: 1552–1563
Acknowledgements
The synopsis was written by Carol Lovegrove, Freelance Medical Writer.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Olsen, N. Alternatives to methotrexate for infliximab combination therapy in rheumatoid arthritis. Nat Rev Rheumatol 2, 472–473 (2006). https://doi.org/10.1038/ncprheum0271
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0271